Kraken Aims to Reshape US Derivatives: Regulated Perpetual Futures on the Horizon
Crypto exchange giant Kraken is making a bold move to bridge the gap between global trading standards and U.S. regulatory requirements. Through its parent company, Payward, Kraken has officially filed to launch the first CFTC-regulated perpetual futures product for eligible American traders, targeting high-demand assets like Bitcoin and Ethereum.
A Regulated Route for High-Demand Products
Kraken is leveraging its acquisition of Bitnomial, a Designated Contract Market (DCM) already registered with the Commodity Futures Trading Commission (CFTC). By routing the product through this established framework, Kraken avoids the "offshore-only" trap that has historically limited U.S. access to perpetual swaps. The proposed product suite is ambitious, covering not just Bitcoin (BTC) and Ethereum (ETH), but also Solana (SOL), XRP, and Cardano (ADA), providing a significantly broader scope for domestic investors looking for sophisticated trading tools.
Why Perpetual Futures Matter for the U.S. Market
Perpetual futures are the lifeblood of the global crypto market because, unlike traditional futures, they do not have fixed expiration dates. This allows traders to maintain positions indefinitely, facilitating more flexible leverage, hedging, and market-making strategies. While these instruments dominate global volumes, the U.S. landscape has remained constrained by strict compliance hurdles, often forcing liquidity to offshore platforms. If successful, Kraken’s filing would signal a major shift in market structure, offering institutional and eligible traders a compliant venue for assets that previously resided in a regulatory grey area.
The Path to Product Reality
Despite the significance of the filing, trading is not yet live. The launch is currently entering a critical 30-day regulatory self-certification review period. During this window, the filing will be scrutinized to ensure the contract structures, surveillance protocols, and disclosure rules meet stringent federal standards. While the market views this as a major step toward bringing "perps" to the United States, the official rollout remains contingent on clearing this final regulatory hurdle without major opposition.
